nb100-360 Search Results


atp7b rabbit polyclonal antibody  (Novus Biologicals)
93
Novus Biologicals atp7b rabbit polyclonal antibody
<t>ATP7B</t> expression in BC cell line. a ATP7B mRNA expression in 13 BC and two non-cancerous cell lines. Error bars, mean ± SEM. b Association between ATP7B mRNA expression levels and the status of conventional biomarkers from CCLE data. ER-positive cells, PgR-positive cells, and HER2-positive cells had significantly higher ATP7B mRNA levels than their negative counterparts. c ATP7B expression in representative BC cell lines. ATP7B expression was detected in MDA-MB-361 and MDA-MB-415, whereas ATP7B was not detected in MDA-MB-231 cells. d qRT-PCR analysis of ATP7B mRNA expression levels after knockdown in MDA-MB-361 and MDA-MB-415 cell lines. e Western blot analysis revealed inhibition of ATP7B after knockdown in MDA-MB-361 and MDA-MB-415 cell lines. ATP7B ATPase copper transforming beta, BC breast cancer, ER estrogen receptor, HER2 human epidermal growth factor receptor 2, si small interfering. * p < 0.05, ** p < 0.01, *** p < 0.001
Atp7b Rabbit Polyclonal Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/atp7b rabbit polyclonal antibody/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
atp7b rabbit polyclonal antibody - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier
polyclonal rabbit anti mouse atp7b  (Novus Biologicals)
94
Novus Biologicals polyclonal rabbit anti mouse atp7b
The changes of ATP7A, <t>ATP7B,</t> and COMMD1 protein levels in the ischemic myocardium. (a) Western blot analysis was performed to detect the protein levels at first, fourth, and seventh day after LAD ligation, ATP7A was not significantly changed, ATP7B was slightly increased only at the first day, and COMMD1 protein levels were significantly increased at the first, fourth, and seventh day. Total protein levels were assayed as a loading control. Data were presented as mean ± SD. *P < 0.01 versus sham control, n = 4 (independent samples for each group). IA: ischemic area.
Polyclonal Rabbit Anti Mouse Atp7b, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit anti mouse atp7b/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
polyclonal rabbit anti mouse atp7b - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

Image Search Results


ATP7B expression in BC cell line. a ATP7B mRNA expression in 13 BC and two non-cancerous cell lines. Error bars, mean ± SEM. b Association between ATP7B mRNA expression levels and the status of conventional biomarkers from CCLE data. ER-positive cells, PgR-positive cells, and HER2-positive cells had significantly higher ATP7B mRNA levels than their negative counterparts. c ATP7B expression in representative BC cell lines. ATP7B expression was detected in MDA-MB-361 and MDA-MB-415, whereas ATP7B was not detected in MDA-MB-231 cells. d qRT-PCR analysis of ATP7B mRNA expression levels after knockdown in MDA-MB-361 and MDA-MB-415 cell lines. e Western blot analysis revealed inhibition of ATP7B after knockdown in MDA-MB-361 and MDA-MB-415 cell lines. ATP7B ATPase copper transforming beta, BC breast cancer, ER estrogen receptor, HER2 human epidermal growth factor receptor 2, si small interfering. * p < 0.05, ** p < 0.01, *** p < 0.001

Journal: Breast Cancer (Tokyo, Japan)

Article Title: ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer

doi: 10.1007/s12282-025-01705-7

Figure Lengend Snippet: ATP7B expression in BC cell line. a ATP7B mRNA expression in 13 BC and two non-cancerous cell lines. Error bars, mean ± SEM. b Association between ATP7B mRNA expression levels and the status of conventional biomarkers from CCLE data. ER-positive cells, PgR-positive cells, and HER2-positive cells had significantly higher ATP7B mRNA levels than their negative counterparts. c ATP7B expression in representative BC cell lines. ATP7B expression was detected in MDA-MB-361 and MDA-MB-415, whereas ATP7B was not detected in MDA-MB-231 cells. d qRT-PCR analysis of ATP7B mRNA expression levels after knockdown in MDA-MB-361 and MDA-MB-415 cell lines. e Western blot analysis revealed inhibition of ATP7B after knockdown in MDA-MB-361 and MDA-MB-415 cell lines. ATP7B ATPase copper transforming beta, BC breast cancer, ER estrogen receptor, HER2 human epidermal growth factor receptor 2, si small interfering. * p < 0.05, ** p < 0.01, *** p < 0.001

Article Snippet: The ATP7B rabbit polyclonal antibody (1:500 dilution) (cat. no. NB100-360; Novus biologicals, LLC., Centennial, CO, USA) was used for immunohistochemistry, and sections were incubated overnight at 4 °C.

Techniques: Expressing, Quantitative RT-PCR, Knockdown, Western Blot, Inhibition

Functional analysis in BC cell lines using knockdown cells. a Proliferation assay: si ATP7B -transfected cell proliferation was significantly enhanced compared to untransfected and siControl-transfected cells. b Invasiveness assay: ATP7B knockdown in BC cells significantly increased the number of invading cells. c Migration assay: the migration ability of MDA-MB-361 and MDA-MB-415 cells was enhanced after si ATP7B transfection. Error bars mean ± SEM. ATP7B ATPase copper transporting beta, BC breast cancer, si small interfering. * p < 0.05, ** p < 0.01, *** p < 0.001

Journal: Breast Cancer (Tokyo, Japan)

Article Title: ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer

doi: 10.1007/s12282-025-01705-7

Figure Lengend Snippet: Functional analysis in BC cell lines using knockdown cells. a Proliferation assay: si ATP7B -transfected cell proliferation was significantly enhanced compared to untransfected and siControl-transfected cells. b Invasiveness assay: ATP7B knockdown in BC cells significantly increased the number of invading cells. c Migration assay: the migration ability of MDA-MB-361 and MDA-MB-415 cells was enhanced after si ATP7B transfection. Error bars mean ± SEM. ATP7B ATPase copper transporting beta, BC breast cancer, si small interfering. * p < 0.05, ** p < 0.01, *** p < 0.001

Article Snippet: The ATP7B rabbit polyclonal antibody (1:500 dilution) (cat. no. NB100-360; Novus biologicals, LLC., Centennial, CO, USA) was used for immunohistochemistry, and sections were incubated overnight at 4 °C.

Techniques: Functional Assay, Knockdown, Proliferation Assay, Transfection, Migration

Association between ATP7B mRNA expression levels and clinicopathological factors. a ATP7B mRNA expression levels did not differ according to T-category, lymph node metastasis, or UICC stage. b ER-positive and PgR-positive samples had significantly higher ATP7B mRNA expression levels than ER-negative and PgR-negative samples; however, no significant difference was found between HER2-positive and HER2-negative specimens. c High ATP7B group experienced longer DFS than the low ATP7B group. d The OS rates in the high ATP7B group were significantly longer than those in the low ATP7B group. a p < 0.05; ATP7B ATPase copper transporting beta, DFS disease‑free survival, ER estrogen receptor, HER2 human epidermal growth factor receptor 2, OS overall survival, PgR progesterone receptor, Tis carcinoma in situ , UICC Union for International Cancer Control

Journal: Breast Cancer (Tokyo, Japan)

Article Title: ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer

doi: 10.1007/s12282-025-01705-7

Figure Lengend Snippet: Association between ATP7B mRNA expression levels and clinicopathological factors. a ATP7B mRNA expression levels did not differ according to T-category, lymph node metastasis, or UICC stage. b ER-positive and PgR-positive samples had significantly higher ATP7B mRNA expression levels than ER-negative and PgR-negative samples; however, no significant difference was found between HER2-positive and HER2-negative specimens. c High ATP7B group experienced longer DFS than the low ATP7B group. d The OS rates in the high ATP7B group were significantly longer than those in the low ATP7B group. a p < 0.05; ATP7B ATPase copper transporting beta, DFS disease‑free survival, ER estrogen receptor, HER2 human epidermal growth factor receptor 2, OS overall survival, PgR progesterone receptor, Tis carcinoma in situ , UICC Union for International Cancer Control

Article Snippet: The ATP7B rabbit polyclonal antibody (1:500 dilution) (cat. no. NB100-360; Novus biologicals, LLC., Centennial, CO, USA) was used for immunohistochemistry, and sections were incubated overnight at 4 °C.

Techniques: Expressing, In Situ, Control

Assessment of ATP7B protein expression status by immunohistochemistry. a Representative staining for the IS and PS of ATP7B. b ATP7B C/N ratio was higher in the high ATP7B group than in the low ATP7B group. c No difference in DFS was found. d The OS rates in the high ATP7B group were significantly longer than those in the low ATP7B group. a p < 0.05; ATP7B ATPase copper transporting beta, DFS disease‑free survival, IS intensity of staining, OS overall survival, PS percentage of staining

Journal: Breast Cancer (Tokyo, Japan)

Article Title: ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer

doi: 10.1007/s12282-025-01705-7

Figure Lengend Snippet: Assessment of ATP7B protein expression status by immunohistochemistry. a Representative staining for the IS and PS of ATP7B. b ATP7B C/N ratio was higher in the high ATP7B group than in the low ATP7B group. c No difference in DFS was found. d The OS rates in the high ATP7B group were significantly longer than those in the low ATP7B group. a p < 0.05; ATP7B ATPase copper transporting beta, DFS disease‑free survival, IS intensity of staining, OS overall survival, PS percentage of staining

Article Snippet: The ATP7B rabbit polyclonal antibody (1:500 dilution) (cat. no. NB100-360; Novus biologicals, LLC., Centennial, CO, USA) was used for immunohistochemistry, and sections were incubated overnight at 4 °C.

Techniques: Expressing, Immunohistochemistry, Staining

The changes of ATP7A, ATP7B, and COMMD1 protein levels in the ischemic myocardium. (a) Western blot analysis was performed to detect the protein levels at first, fourth, and seventh day after LAD ligation, ATP7A was not significantly changed, ATP7B was slightly increased only at the first day, and COMMD1 protein levels were significantly increased at the first, fourth, and seventh day. Total protein levels were assayed as a loading control. Data were presented as mean ± SD. *P < 0.01 versus sham control, n = 4 (independent samples for each group). IA: ischemic area.

Journal: Experimental Biology and Medicine

Article Title: Featured Article: The loss of copper is associated with the increase in copper metabolism MURR domain 1 in ischemic hearts of mice

doi: 10.1177/1535370218773055

Figure Lengend Snippet: The changes of ATP7A, ATP7B, and COMMD1 protein levels in the ischemic myocardium. (a) Western blot analysis was performed to detect the protein levels at first, fourth, and seventh day after LAD ligation, ATP7A was not significantly changed, ATP7B was slightly increased only at the first day, and COMMD1 protein levels were significantly increased at the first, fourth, and seventh day. Total protein levels were assayed as a loading control. Data were presented as mean ± SD. *P < 0.01 versus sham control, n = 4 (independent samples for each group). IA: ischemic area.

Article Snippet: Equal amounts of total proteins were separated by SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membrane, which was incubated with primary antibodies: monoclonal mouse anti-mouse ATP7A (163 kDa, ab131400, Abcam, UK), polyclonal rabbit anti-mouse ATP7B (165 kDa, NB100-360, Novus biologicals, USA), and monoclonal mouse anti-mouse COMMD1 (21 kDa, sc-166248, Santa Cruz, USA), followed by hybridization with appropriate secondary antibodies.

Techniques: Western Blot, Ligation, Control